Participate in an Asthma Clinical Trial

Last updated: December 22, 2023
Sponsor: CIPLA
Overall Status: Active - Recruiting

Phase

3

Condition

Asthma

Treatment

N/A

Clinical Study ID

TX322057
CRD/58
  • Ages 18-65
  • All Genders

Study Summary

We are currently recruiting people who have stable mild asthma to participate in a clinical research study to compare study drugs.

Eligibility Criteria

Inclusion

Inclusion Criteria

To be eligible, participants must be:

  • 18-65 years of age
  • Able to attend up to 7 office visits within approximately 11 weeks (each visit will take between 3 - 9 hours)

*Additional criteria may apply

Those who qualify will receive:

  • Study-related exams, including pulmonary function testing
  • Compensation for time and travel
  • Dose in the office using inhalers containing study drug or placebo

Study Design

Study Start date:
October 02, 2023
Estimated Completion Date:
May 31, 2024

Study Description

North Carolina Clinical Research is looking for participants to take part in a research study comparing study drugs. You may be eligible if you are 18-65 years of age, have stable mild asthma, and are able to attend up to 7 office visits.   Participants will receive study related exams, including pulmonary function testing, inhalers containing study drug or placebo will be provided in the office, and compensation for time and travel.

Connect with a study center

  • North Carolina Clinical Research

    Raleigh, NC 27607
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.